CXCL2 acts as a prognostic biomarker and associated with immune infiltrates in stomach adenocarcinoma

STAD ranked 5th most common in the incidence of malignant tumors and 3rd most common in the death rate of cancer worldwide. CXC chemokines affect the biological progress of various tumors, resulting in therapeutic failure. The role of CXCL2 in STAD was still a mystery. METHODS: The expression, progn...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Jingxin, Hou, Wenji, Zuo, Junbo, Huang, Zhenhua, Ding, Xin, Bu, Xuefeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
5700
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9592451/
https://www.ncbi.nlm.nih.gov/pubmed/36281171
http://dx.doi.org/10.1097/MD.0000000000031096

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9592451/
https://www.ncbi.nlm.nih.gov/pubmed/36281171
http://dx.doi.org/10.1097/MD.0000000000031096

Ejemplares similares